Depo Provera Meningioma Lawsuits for New York Residents

Risk of Meningioma is Fivefold for New York Depo Provera Users

After decades of relying on Depo Provera (medroxyprogesterone acetate), the birth control injection used by more than 74 million women worldwide, New York women are learning Depo Provera increases the risk of brain tumors known as meningiomas by more than fivefold. Two other drugs prescribed to women in New York, medrogestone and promegestone, increase the risk of meningiomas by 4.1 times and 2.7 times respectively, according to a comprehensive French study.

Depo Provera Meningioma Lawsuits from New York Residents

Persons and family members of persons in New York who developed meningioma brain tumors and have a history of using Depo Provera or another high-progestin drug may be entitled to compensation through filing Depo Provera meningioma lawsuits for New York residents. Individuals who match this description are eligible for free, no-obligation case reviews with an attorney handling Depo Provera lawsuits for meningioma claims in New York. Meningioma lawsuits from New York residents against the drugmakers are the most effective path for consumers to recover compensation and hold the company accountable for the harm Depo Provera has caused. Lawyers handling Depo Provera lawsuits for New York meningioma brain tumors work on contingency, meaning you will never pay legal fees unless we win compensation for you. Read full information on filing Depo Provera meningioma lawsuits for New York residents.

Depo Provera Tumor Lawsuit FAQs for New York Residents

This page provides answers to common questions about filing a Depo Provera lawsuit for New York residents. Compiled by attorneys handling Depo Provera brain tumor lawsuits for New York claims, this information applies to most general questions regarding lawsuits against the makers of Depo Provera, medrogestone and promegestone for meningioma brain tumors in New York. Our attorneys handling Depo Provera brain tumor lawsuit claims for New York residents also offer free, no-obligation case consultation. If you still have questions after reading this page or you would prefer to speak directly with a lawyer handling Depo Provera lawsuits for New York families, please complete our contact form. Read full New York Depo Provera brain tumor lawsuit questions and answers.

Depo Provera Brain Tumor Attorneys Serving New York

If you or a member of your family was harmed by a dangerous drug, finding the right legal representation is key. Our Depo Provera brain tumor attorneys serving New York have a long track record of success against billion dollar pharmaceutical corporations, winning compensation for individuals and families harmed by corporate negligence and greed. When a multinational pharmaceutical corporation appears to be profiting at the expense of consumer safety, our Depo Provera brain tumor lawyers for New York cases see it as our mission to pursue justice no matter how complex the case. Our attorneys handling New York meningioma brain tumor cases for persons who have taken Depo Provera, medrogestone or promegestone in New York help individuals recover the compensation they need and deserve, while holding companies accountable for wrongdoing and harm. Read full information for filing a claim with Depo Provera brain tumor lawyers for New York claims.

New York Residents: Depo Provera Brain Tumor Information

New research out of France shows that women in New York who take a high-progestin drug such as Depo Provera, medrogestone or promegestone for at least a year are five times more likely to develop a type of brain tumor known as meningioma than their peers. While meningioma brain tumors in New York women are most often not cancerous, they still pose significant risks. Treatment of Depo Provera brain tumors in New York often involves neurosurgery, putting patients in danger of seizures, brain damage, long term disability, and death. Women in New York took Depo Provera with no warning about the risk of brain tumors. Persons and family members of persons who have developed a brain tumor in New York after taking Depo Provera or another high-progestin drug for at least a year may be eligible for compensation. Read full information on Depo Provera brain tumors for New York residents.

Depo Provera Meningioma Information for New York Residents

Meningioma is a type of brain tumor occuring in New York that has recently been linked to the use of high-progestin drugs including Depo Provera, medrogestone and promegestone. Research published in the British Medical Journal in 2024 estimated that New York women who use Depo Provera for at least a year are five times more likely to develop meningiomas than women who do not use the drug. Meningioma typically requires brain surgery and can cause serious and long-term health problems, disability, and death. Believing Depo Provera to be a safe method of birth control, countless women in New York have been exposed to the risk of Depo Provera meningioma at no fault of their own, and those who developed a brain tumor may be eligible for significant compensation. Read full information on Depo Provera meningioma for New York residents.

For decades, women in New York have relied on Depo Provera, medrogestone and promegestone with no knowledge of the heightened risk for brain tumors. Intracranial meningiomas are tumors that grow in the layers of tissue covering the spinal cord and the brain. While the majority of meningiomas in New York are not cancerous, they typically require brain surgery or radiation, and they can recur over time. Brain surgery itself carries significant risks for New York women including seizures and damage to brain tissue and vasculature, which can cause serious and permanent injury and disability.

Originally developed by Upjohn Company (a subsidiary of Pfizer) in the 1950s, Depo Provera is now marketed in New York and around the globe by Pfizer and is also available in New York as a generic from several other pharmaceutical companies. In its many decades of marketing Depo Provera as a safe and reliable form of birth control, Pfizer failed to warn New York women of the risk of Depo Provera meningioma. For a company that garnered $58.5 billion in 2023 alone, critics question whether the company has done all it could to ensure the drug was safe. It took the work of independent researchers in France to identify the connection between Depo Provera and meningioma, after millions of women, including women in New York, were exposed to the risk over multiple decades.

No Fees Unless We Collect for You - Our Depo Provera Meningioma Attorneys Represent New York Clients on a Contingency Basis

Now, women and family members of women in New York who have been diagnosed with meningioma after taking Depo Provera, medrogestone and promegestone are seeking to hold the manufacturers accountable for the resulting harm. Women and the family members of women in New York who took Depo Provera or another high-progestogen drug for one year or longer and then developed meningioma may be entitled to significant compensation through filing New York Depo Provera meningioma lawsuits against the manufacturer.